Washington, DC (PRWEB) July 5, 2008
Strategic Pharmaceutical Advisors (SRxA), a leading U.S. healthcare strategic marketing consulting and education firm proudly announced the formation of its European affiliate Strategic Respiratory Advisors - Europe (SRxA-Europe).
SRxA-Europe will be led by G. Walter Canonica, MD, of Genoa University, Genoa, Italy and President of the World Allergy Organization; Jean Bousquet, MD, of the University of Montpellier, Montpellier, France; Sergio Bonini, MD , Second University of Naples and INMM-CNR, ARTOV, Rome, Italy, and Stephen Holgate, MD, of Southampton University School of Medicine, Southampton, UK. These experts will work closely with their
U.S. Affiliates to provide clients with access to the highest echelon of
Respiratory Thought Leaders worldwide.
"Since its inception, SRxA has successfully assisted pharmaceutical
companies with educational, clinical, regulatory, and marketing support programs in the U.S. The newest affiliate represents a key step in the growth of our services to address the needs of our pharmaceutical clients globally" said Christos Efessiou, SRxA's Chief Executive Officer commenting on the planned expansion of the company.
SRxA operates on a unique business model that utilizes clinical teams of national and international experts who partner with experts in industry and communications to provide the latest information and education in allergy, asthma, immunology, pulmonary diseases, and otolaryngology.
Other SRxA affiliates operating in the United States include Strategic
Allergy Advisors (SAA), Strategic Pulmonary Advisors (SPA), and Strategic Ear, Nose and Throat Advisors (SENTA). The company plans to introduce new affiliates in other key specialties in the near future.
SRxA is headquartered in Washington, DC with offices in London and Hong Kong. For more information please visit our website http://www.srxa.com
Christos S. Efessiou
Email : cefessiou @ SRxA.com